Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intermediate Versus Standard Dose Enoxaparin to Prevent Venous Thromboembolism in Severe Trauma Patients: a Multicenter Double Blind Randomised Controlled Trial

NCT07506473 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.

NCT NCT07506473
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07506473 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intermediate Versus Standard Dose Enoxaparin to Prevent Venous Thromboembolism in Severe Trauma Patients: a Multicenter Double Blind Randomised Controlled Trial
Lead sponsor
University Hospital, Grenoble
Phase
Not applicable
Overall status
Not yet recruiting
Start date
April 30, 2026
Completion date
May 31, 2028
Enrollment
540 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

severe trauma patient, venous thromboembolism